Goro Yoshioka

Dr. Goro Yoshioka

Saga University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Closed access
KNKensaku Nishihira
Kensaku Nishihira
GYGoro Yoshioka
Goro Yoshioka
NKNehiro Kuriyama
Nehiro Kuriyama
KOKenji Ogata
Kenji Ogata
TKToshiyuki Kimura
Toshiyuki Kimura
YSYoshisato Shibata
Yoshisato Shibata
Aims : Frailty is characterized by reduced biological reserves and weakened resistance to stressors, and is common in older adults. This study evaluated the prognostic implications of frailty at hospitalization in elderly patients with acute myocardial infarction (AMI) who undergo percutaneous coronary intervention (PCI). Methods and results : We prospectively analysed 546 AMI patients aged ≥80 years undergoing PCI from 2009 to 2017. Frailty was classified based on impairment in walking (unassisted, assisted, and wheelchair/non-ambulatory), cognition (normal, mildly impaired, moderately to severely impaired), and basic activities of daily living. Impairment in each domain was scored as 0, 1, or 2, and patients were categorized into the following three groups based on total score: no frailty (0), mild frailty (1–2), moderate-to-severe frailty (≥3). The median follow-up period was 589 days. Of the 546 patients, 27.8% were frail (mild or moderate-to-severe), and this proportion significantly increased to 35.5% at discharge (P < 0.001). Compared to non-frail patients, frail patients were older, less likely to be male, and had a higher rate of advanced Killip class. Major bleeding (no frailty, 9.6%; mild frailty, 16.9%; moderate-to-severe frailty, 31.8%; P < 0.001) and in-hospital mortality (no frailty, 8.4%; mild frailty, 15.4%; moderate-to-severe frailty, 27.3%; P < 0.001) increased as frailty worsened. After adjusting for confounders, frailty was independently associated with higher mid-term all-cause mortality (hazard ratio, 1.81; 95% confidence interval, 1.23–2.65; P = 0.002). Conclusion : Frailty in AMI patients aged ≥80 years undergoing PCI was associated with major bleeding, in-hospital death, and mid-term mortality.

5 October 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
GYGoro Yoshioka
Goro Yoshioka
ATAtsushi Tanaka
Atsushi Tanaka
KNKensaku Nishihira
Kensaku Nishihira
MNMasahiro Natsuaki
Masahiro Natsuaki
AKAtsushi Kawaguchi
Atsushi Kawaguchi
KNKoichi Node
Koichi Node
Aims Previous studies have suggested that low serum albumin (LSA) at admission for acute myocardial infarction (AMI) is associated with adverse in-hospital outcomes. The aim of this study was to investigate whether LSA in the remote phase after AMI is prognostic for long-term outcomes. Methods and results This was a single-centre, retrospective study of consecutive patients admitted for AMI from 2008 to 2016. Serum albumin concentrations were measured serially at admission and 1 year after discharge in Japanese patients. Occurrence of a composite of hospitalization for heart failure and cardiovascular death was the primary endpoint. The prognostic impact of remote LSA, defined as a serum albumin level < 3.8 g/dL at 1 year after discharge, was investigated with a multivariate-adjusted Cox model. Among 1424 subjects analysed, 289 (20.3%) had LSA at admission, and 165 (11.6%) had LSA at 1 year after discharge. During follow-up (median: 4.1 years), the primary endpoint occurred in 31/165 (18.8%) patients with remote LSA and 42/1259 (3.3%) patients without it [adjusted hazard ratio (aHR), 2.76; 95% confidence interval (CI), 1.32 to 5.72; P = 0.007]. The all-cause death rate was 29.7% (49/165) in patients with remote LSA and 4.3% (54/1259) in patients without it (aHR, 4.02; 95% CI, 2.36 to 6.87; P < 0.001). The prognostic impact of remote LSA was consistent across albumin status in the acute phase of AMI. Conclusions Regardless of albumin status in the acute phase of AMI, LSA in the remote phase after AMI was significantly associated with long-term adverse outcomes.

29 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
GYGoro Yoshioka
Goro Yoshioka
ATAtsushi Tanaka
Atsushi Tanaka
KNKensaku Nishihira
Kensaku Nishihira
YSYoshisato Shibata
Yoshisato Shibata
KNKoichi Node
Koichi Node
Low serum albumin (LSA) on admission for acute myocardial infarction (AMI) is related to adverse in-hospital outcomes. However, the relationship between LSA and long-term post-AMI cardiovascular outcomes is unknown. A single-center, non-randomized, retrospective study was performed to investigate the prognostic impact of LSA at admission for AMI on cardiovascular death or newly developed HF in the remote phase after AMI. Admission serum albumin tertiles (<3.8, 3.8–4.2, ≥4.2 g/dL) were used to divide 2253 consecutive AMI from February 2008 to January 2016 patients into three groups. Primary outcome was a composite of hospitalization for HF and cardiovascular death remotely after AMI. Cox proportional hazard models were used to explore the relationship between admission LSA and primary outcome. During follow-up (median: 3.2 years), primary composite outcome occurred in 305 patients (13.5%). Primary composite outcome occurred individually for hospitalization for HF in 146 patients (6.5%) and cardiovascular death in 192 patients (8.5%). The cumulative incidence of primary composite outcome was higher in the LSA group than the other groups (log-rank test, p < 0.001). Even after adjustments for relevant clinical variables, LSA (<3.8 mg/dL) was an independent predictor of remote-phase primary composite outcome, irrespective of the clinical severity and subtype of AMI. Thus, LSA on admission for AMI was an independent predictor of newly developed HF or cardiovascular death and has a useful prognostic impact even remotely after AMI.

29 September 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
GYGoro Yoshioka
Goro Yoshioka
ATAtsushi Tanaka
Atsushi Tanaka
NWNozomi Watanabe
Nozomi Watanabe
KNKensaku Nishihira
Kensaku Nishihira
MNMasahiro Natsuaki
Masahiro Natsuaki
KNKoichi Node
Koichi Node
Introduction: We sought to investigate the prognostic impact of incident left ventricular (LV) systolic dysfunction at the chronic phase of acute myocardial infarction (AMI).Materials and methods: Among 2,266 consecutive patients admitted for AMI, 1,330 patients with LV ejection fraction (LVEF) ≥ 40% during hospitalization who had LVEF data at 6 months after AMI were analyzed. Patients were divided into three subgroups based on LVEF at 6 months: reduced-LVEF (<40%), mid-range-LVEF (≥ 40% and < 50%) and preserved-LVEF (≥ 50%). Occurrence of a composite of hospitalization for heart failure or cardiovascular death after 6 months of AMI was the primary endpoint. The prognostic impact of LVEF at 6 months was assessed with a multivariate-adjusted Cox model.Results: Overall, the mean patient age was 67.5 ± 11.9 years, and LVEF during initial hospitalization was 59.4 ± 9.1%. The median (interquartile range) duration of follow-up was 3.0 (1.5–4.8) years, and the primary endpoint occurred in 35/1330 (2.6%) patients (13/69 [18.8%] in the reduced-LVEF, 9/265 [3.4%] in the mid-range-LVEF, and 13/996 [1.3%] in the preserved-LVEF category). The adjusted hazard ratio for the primary endpoint in the reduced-LVEF vs. mid-range-LVEF category and in the reduced-LVEF vs. preserved-LVEF category was 4.71 (95% confidence interval [CI], 1.83 to 12.13; p < 0.001) and 14.37 (95% CI, 5.38 to 38.36; p < 0.001), respectively.Conclusion: Incident LV systolic dysfunction at the chronic phase after AMI was significantly associated with long-term adverse outcomes. Even in AMI survivors without LV systolic dysfunction at the time of AMI, post-AMI reassessment and careful monitoring of LVEF are required to identify patients at risk.

Verified
Journal Article
Open access
PDF file
YGYuhei Goriki
Yuhei Goriki
ATAtsushi Tanaka
Atsushi Tanaka
GYGoro Yoshioka
Goro Yoshioka
KNKensaku Nishihira
Kensaku Nishihira
NKNehiro Kuriyama
Nehiro Kuriyama
KNKoichi Node
Koichi Node
The high post-discharge mortality rate of acute myocardial infarction (AMI) survivors is concerning, indicating a need for reliable, easy-to-use risk prediction tools. We aimed to examine if a combined pre-procedural blood testing risk model predicts one-year mortality in AMI survivors. Overall, 1355 consecutive AMI patients who received primary coronary revascularization were divided into derivation (n = 949) and validation (n = 406) cohorts. A risk-score model of parameters from pre-procedural routine blood testing on admission was generated. In the derivation cohort, multivariable analysis demonstrated that hemoglobin < 11 g/dL (odds ratio (OR) 4.01), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (OR 3.75), albumin < 3.8 mg/dL (OR 3.37), and high-sensitivity troponin I > 2560 ng/L (OR 3.78) were significantly associated with one-year mortality after discharge. An increased risk score, assigned from 0 to 4 points according to the counts of selected variables, was significantly associated with higher one-year mortality in both cohorts (p < 0.001). Receiver-operating characteristics curve analyses of risk models demonstrated adequate discrimination between patients with and without one-year death (area under the curve (95% confidence interval) 0.850 (0.756–0.912) in the derivation cohort; 0.820 (0.664–0.913) in the validation cohort). Our laboratory risk-score model can be useful for predicting one-year mortality in AMI survivors.

17 July 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
GYGoro Yoshioka
Goro Yoshioka
KNKensaku Nishihira
Kensaku Nishihira
YSYoshisato Shibata
Yoshisato Shibata
KNKoichi Node
Koichi Node
A 65-year-old man without coronary risk factors was hospitalized due to frequent chest pain at rest in the early morning. Although electrocardiography showed no significant findings of myocardial ischaemia, his serum troponin I level was elevated at 0.3303 ng/mL (the normal level: <0.032 ng/mL). He was diagnosed with non-ST-elevation acute coronary syndrome (NSTE-ACS) and underwent cardiac catheterization. Coronary angiography revealed severe stenosis in the middle left anterior descending (LAD) coronary artery (Panels A1 and A2). Optical coherence tomography (OCT) imaging for detailed evaluation of the bifurcation lesion showed mural thrombus (Panel B1, asterisk) and multiple channels called a ‘lotus root-like appearance’ without atherosclerosis (Panels B2–B4). The lesion was dilated successfully using a cutting balloon (as the first choice) and a drug-coated balloon (Panel A3). Since vasospastic angina was suspected due to his medical history and absence of atherosclerotic changes around the lesion on OCT imaging, we performed a spasm provocation test 1 month after coronary intervention. After intracoronary injection of ergonovine which causes vascular smooth muscle contraction mainly via activation of serotonergic receptors, he complained of chest pain, and electrocardiography showed ST-segment elevation (Panel C). Coronary angiography demonstrated total occlusion of LAD (Panel D, arrowhead). Thus, he was diagnosed with vasospastic angina.